Abstract
The UK High Court has granted an injunction allowing Chiron Corporation a monopoly in selling hepatitis C virus test kits. The decision will be welcomed by the pharmaceutical and biotechnology industries.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moss, G., Cohen, S. Patents in the public interest. Nature 372, 814 (1994). https://doi.org/10.1038/372814a0
Issue date:
DOI: https://doi.org/10.1038/372814a0
